US Patent Issued to Regeneron Pharmaceuticals, University of Maryland, Baltimore on Nov. 25 for "B4GALT1 variants and uses thereof" (Maryland, New York Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,103, issued on Nov. 25, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.) and University of Maryland, Baltimore (Baltimore).

"B4GALT1 variants and uses thereof" was invented by May Montasser (Baltimore), Cristopher Van Hout (Tarrytown, N.Y.), Alan Shuldiner (Tarrytown, N.Y.), Giusy Della Gatta (Tarrytown, N.Y.), Matthew Healy (Tarrytown, N.Y.) and Marja Puurunen (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Variant B4GALT1 genomic, mRNA, and cDNA nucleic acid molecules, and polypeptides, methods of detecting the presence of these molecules, methods of modulating endogenous B4GALT1 genomic, mRNA, and cDNA nucleic acid...